Colin F. Greineder, Ph.D. - Publications

2014 Pharmacology University of Pennsylvania, Philadelphia, PA, United States 
Pharmacology, Biomedical Engineering

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Marcos-Contreras OA, Brenner JS, Kiseleva RY, Zuluaga-Ramirez V, Greineder CF, Villa CH, Hood ED, Myerson JW, Muro S, Persidsky Y, Muzykantov VR. Combining vascular targeting and the local first pass provides 100-fold higher uptake of ICAM-1-targeted vs untargeted nanocarriers in the inflamed brain. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30871995 DOI: 10.1016/j.jconrel.2019.03.008  0.76
2018 Hood ED, Greineder CF, Shuvaeva T, Walsh L, Villa CH, Muzykantov VR. Vascular targeting of radiolabeled liposomes with bio-orthogonally conjugated ligands: single chain fragments provide higher specificity than antibodies. Bioconjugate Chemistry. PMID 30240185 DOI: 10.1021/acs.bioconjchem.8b00564  0.76
2018 Myerson JW, Braender B, Mcpherson O, Glassman PM, Kiseleva RY, Shuvaev VV, Marcos-Contreras O, Grady ME, Lee HS, Greineder CF, Stan RV, Composto RJ, Eckmann DM, Muzykantov VR. Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles. Advanced Materials (Deerfield Beach, Fla.). e1802373. PMID 29956381 DOI: 10.1002/adma.201802373  0.76
2018 Khoshnejad M, Greineder CF, Pulsipher KW, Villa CH, Altun B, Pan DC, Tsourkas A, Dmochowski IJ, Muzykantov V. Ferritin nanocages with biologically orthogonal conjugation for vascular targeting and imaging. Bioconjugate Chemistry. PMID 29429330 DOI: 10.1021/acs.bioconjchem.8b00004  0.48
2018 Khoshnejad M, Brenner JS, Motley W, Parhiz H, Greineder CF, Villa CH, Marcos-Contreras OA, Tsourkas A, Muzykantov VR. Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9. Scientific Reports. 8: 1760. PMID 29379029 DOI: 10.1038/s41598-018-19784-2  0.76
2018 Villa CH, Pan DC, Johnston IH, Greineder CF, Walsh LR, Hood ED, Cines DB, Poncz M, Siegel DL, Muzykantov VR. Biocompatible coupling of therapeutic fusion proteins to human erythrocytes. Blood Advances. 2: 165-176. PMID 29365311 DOI: 10.1182/bloodadvances.2017011734  0.76
2017 Greineder CF, Johnston IH, Villa CH, Gollomp K, Esmon CT, Cines DB, Poncz M, Muzykantov VR. ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model. Blood Advances. 1: 1452-1465. PMID 29296786 DOI: 10.1182/bloodadvances.2017007229  0.76
2017 Kiseleva RY, Glassman PM, Greineder CF, Hood ED, Shuvaev VV, Muzykantov VR. Targeting therapeutics to endothelium: are we there yet? Drug Delivery and Translational Research. PMID 29282646 DOI: 10.1007/s13346-017-0464-6  0.76
2017 Brenner JS, Kiseleva RY, Glassman PM, Parhiz H, Greineder CF, Hood ED, Shuvaev VV, Muzykantov VR. EXPRESS: The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety. Pulmonary Circulation. 2045893217752329. PMID 29261028 DOI: 10.1177/2045893217752329  0.76
2017 Greineder CF, Villa CH, Walsh LR, Kiseleva RY, Hood ED, Khoshnejad M, Warden-Rothman R, Tsourkas A, Muzykantov VR. Site-specific modification of single-chain antibody fragments for bioconjugation and vascular immunotargeting. Bioconjugate Chemistry. PMID 29200285 DOI: 10.1021/acs.bioconjchem.7b00592  0.76
2017 Kiseleva R, Greineder CF, Villa CH, Hood ED, Shuvaev VV, Sun J, Chacko AM, Abraham V, DeLisser HM, Muzykantov VR. Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1. Plos One. 12: e0169537. PMID 28085903 DOI: 10.1371/journal.pone.0169537  0.76
2017 Brenner JS, Bhamidipati K, Glassman P, Ramakrishnan N, Jiang D, Paris AJ, Myerson JW, Pan DC, Shuvaev VV, Villa C, Hood ED, Kiseleva R, Greineder CF, Radhakrishnan R, Muzykantov VR. Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions. Nanomedicine : Nanotechnology, Biology, and Medicine. PMID 28065731 DOI: 10.1016/j.nano.2016.12.019  0.76
2016 Carnemolla R, Villa CH, Greineder CF, Zaitsev S, Patel KR, Kowalska MA, Atochin DN, Cines DB, Siegel DL, Esmon CT, Muzykantov VR. Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27836986 DOI: 10.1096/fj.201600912R  0.76
2016 Greineder CF, Hood ED, Yao A, Khoshnejad M, Brenner JS, Johnston IH, Poncz M, Gottstein C, Muzykantov VR. Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26855052 DOI: 10.1016/j.jconrel.2016.02.006  0.48
2015 Khoshnejad M, Shuvaev V, Pulsipher KW, Dai C, Hood ED, Arguiri E, Christofidou-Solomidou M, Dmochowski IJ, Greineder CF, Muzykantov VR. Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles. Bioconjugate Chemistry. PMID 26718023 DOI: 10.1021/acs.bioconjchem.5b00641  0.76
2015 Chacko AM, Han J, Greineder CF, Zern BJ, Mikitsh JL, Nayak M, Menon D, Johnston IH, Poncz M, Eckmann DM, Davies PF, Muzykantov VR. Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement. Acs Nano. 9: 6785-93. PMID 26153796 DOI: 10.1021/nn505672x  0.76
2015 Greineder CF, Brenza JB, Carnemolla R, Zaitsev S, Hood ED, Pan DC, Ding BS, Esmon CT, Chacko AM, Muzykantov VR. Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 25953848 DOI: 10.1096/fj.15-271213  0.48
2015 Myerson JW, Brenner JS, Greineder CF, Muzykantov VR. Systems approaches to design of targeted therapeutic delivery. Wiley Interdisciplinary Reviews. Systems Biology and Medicine. PMID 25946066 DOI: 10.1002/wsbm.1304  0.48
2014 Howard MD, Hood ED, Greineder CF, Alferiev IS, Chorny M, Muzykantov V. Targeting to endothelial cells augments the protective effect of novel dual bioactive antioxidant/anti-inflammatory nanoparticles. Molecular Pharmaceutics. 11: 2262-70. PMID 24877560 DOI: 10.1021/mp400677y  0.48
2014 Hood ED, Chorny M, Greineder CF, S Alferiev I, Levy RJ, Muzykantov VR. Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation. Biomaterials. 35: 3708-15. PMID 24480537 DOI: 10.1016/j.biomaterials.2014.01.023  0.48
2014 Howard MD, Greineder CF, Hood ED, Muzykantov VR. Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 177: 34-41. PMID 24412573 DOI: 10.1016/j.jconrel.2013.12.035  0.48
2013 Greineder CF, Chacko AM, Zaytsev S, Zern BJ, Carnemolla R, Hood ED, Han J, Ding BS, Esmon CT, Muzykantov VR. Vascular immunotargeting to endothelial determinant ICAM-1 enables optimal partnering of recombinant scFv-thrombomodulin fusion with endogenous cofactor. Plos One. 8: e80110. PMID 24244621 DOI: 10.1371/journal.pone.0080110  0.48
2013 Carnemolla R, Greineder CF, Chacko AM, Patel KR, Ding BS, Zaitsev S, Esmon CT, Muzykantov VR. Platelet endothelial cell adhesion molecule targeted oxidant-resistant mutant thrombomodulin fusion protein with enhanced potency in vitro and in vivo. The Journal of Pharmacology and Experimental Therapeutics. 347: 339-45. PMID 23965383 DOI: 10.1124/jpet.113.205104  0.48
2013 Greineder CF, Howard MD, Carnemolla R, Cines DB, Muzykantov VR. Advanced drug delivery systems for antithrombotic agents. Blood. 122: 1565-75. PMID 23798715 DOI: 10.1182/blood-2013-03-453498  0.48
2013 Zern BJ, Chacko AM, Liu J, Greineder CF, Blankemeyer ER, Radhakrishnan R, Muzykantov V. Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. Acs Nano. 7: 2461-9. PMID 23383962 DOI: 10.1021/nn305773f  0.48
2012 Hood ED, Greineder CF, Dodia C, Han J, Mesaros C, Shuvaev VV, Blair IA, Fisher AB, Muzykantov VR. Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo Journal of Controlled Release. 163: 161-169. PMID 22974832 DOI: 10.1016/j.jconrel.2012.08.031  0.48
2012 Chacko AM, Nayak M, Greineder CF, Delisser HM, Muzykantov VR. Collaborative enhancement of antibody binding to distinct PECAM-1 epitopes modulates endothelial targeting. Plos One. 7: e34958. PMID 22514693 DOI: 10.1371/journal.pone.0034958  0.48
2007 Greineder CF, Nelson PW, Dressel AL, Erba HP, Younger JG. In vitro and in silico analysis of annexin V binding to lymphocytes as a biomarker in emergency department sepsis studies. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 14: 763-71. PMID 17463469 DOI: 10.1197/j.aem.2007.01.017  0.48
2005 Ben-David I, Price SE, Bortz DM, Greineder CF, Cohen SE, Bauer AL, Jackson TL, Younger JG. Dynamics of intrapulmonary bacterial growth in a murine model of repeated microaspiration. American Journal of Respiratory Cell and Molecular Biology. 33: 476-82. PMID 16014897 DOI: 10.1165/rcmb.2005-0053OC  0.48
Show low-probability matches.